SVRA Savara Inc

Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.

$1.52  -0.02 (-1.30%)
As of 06/30/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/20/2002
Outstanding shares:  114,041,271
Average volume:  202,236
Market cap:   $175,623,557
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.28
PS ratio:   0.00
Return on equity:   -30.11%
Net income %:   0.00%